Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

629 ARTÍCULOS , VIENDO DEL 31 AL 45

Arterial Changes Connecting Hypertension to Alzheimer's Disease and Related Dementias

Burke GL, Hughes TM.

JACC Cardiovasc Imaging. 2021 Jan;14(1):186-188. doi: 10.1016/j.jcmg.2020.10.018.

Cognitive Reserve, Alzheimer's Neuropathology, and Risk of Dementia: A Systematic Review and Meta-Analysis

Nelson ME, Jester DJ, Petkus AJ, Andel R.

Neuropsychol Rev. 2021 Jun;31(2):233-250. doi: 10.1007/s11065-021-09478-4. Epub 2021 Jan 8.

Hypertriglyceridemia and Alzheimer Disease: Opening the Mind to New Therapeutic Opportunities

Watts GF, Mamo JCL.

Clin Chem. 2021 Jan 8;67(1):6-8. doi: 10.1093/clinchem/hvaa294.

The Association between Vision Impairment and Incidence of Dementia and Cognitive Impairment: A Systematic Review and Meta-analysis

Shang X, Zhu Z, Wang W, Ha J, He M.

Ophthalmology. 2021 Aug;128(8):1135-1149. doi: 10.1016/j.ophtha.2020.12.029. Epub 2021 Jan 8.

Experimental Rodent Models of Vascular Dementia: A Systematic Review

Tiwari N, Upadhyay J, Ansari MN, Raza SS, Ahmad W, Ansari MA.

CNS Neurol Disord Drug Targets. 2021;20(7):657-672. doi: 10.2174/1871527319666210108123438.

Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline

Liu X, Morris MC, Dhana K, Ventrelle J, Johnson K, Bishop L, Hollings CS, Boulin A, Laranjo N, Stubbs BJ, Reilly X, Carey VJ, Wang Y, Furtado JD, Marcovina SM, Tangney C, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL.

Contemp Clin Trials. 2021 Mar;102:106270. doi: 10.1016/j.cct.2021.106270. Epub 2021 Jan 9.

Imaging of vascular cognitive impairment

Razek AAKA, Elsebaie NA.

Clin Imaging. 2021 Jun;74:45-54. doi: 10.1016/j.clinimag.2020.12.038. Epub 2021 Jan 7.

Endocrine dysfunction and cognitive impairment

Calsolaro V, Bottari M, Coppini G, Lemmi B, Monzani F.

Minerva Endocrinol (Torino). 2021 Sep;46(3):335-349. doi: 10.23736/S2724-6507.20.03295-2. Epub 2021 Jan 12.

Preventing dementia? Interventional approaches in mild cognitive impairment

Lissek V, Suchan B.

Neurosci Biobehav Rev. 2021 Mar;122:143-164. doi: 10.1016/j.neubiorev.2020.12.022. Epub 2021 Jan 10.

Crocus Sativus L. (Saffron) in Alzheimer's Disease Treatment: Bioactive Effects on Cognitive Impairment

D'Onofrio G, Nabavi SM, Sancarlo D, Greco A, Pieretti S.

Curr Neuropharmacol. 2021;19(9):1606-1616. doi: 10.2174/1570159X19666210113144703.

New approaches to symptomatic treatments for Alzheimer's disease

Cummings J.

Mol Neurodegener. 2021 Jan 13;16(1):2. doi: 10.1186/s13024-021-00424-9.

Preservation of Memory in Alzheimer-Related Primary Progressive Aphasia: Glass Half Full

Sajjadi SA, Ash S, Cappa S.

Neurology. 2021 Feb 9;96(6):243-244. doi: 10.1212/WNL.0000000000011404. Epub 2021 Jan 13.

Parosmia in Right-lateralized Semantic Variant Primary Progressive Aphasia: A Case Report

Joo JY, Kim HG, Lee KM, Ko SH, Rhee HY, Park KC, Lee JS.

Alzheimer Dis Assoc Disord. 2021 Apr-Jun 01;35(2):160-163. doi: 10.1097/WAD.0000000000000429.

Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy

Liguori C, Spanetta M, Romoli M, Placidi F, Nardi Cesarini E, Mercuri NB, Costa C.

Mech Ageing Dev. 2021 Mar;194:111434. doi: 10.1016/j.mad.2021.111434. Epub 2021 Jan 11.

Classification accuracy of TMS for the diagnosis of mild cognitive impairment

Benussi A, Grassi M, Palluzzi F, Cantoni V, Cotelli MS, Premi E, Di Lorenzo F, Pellicciari MC, Ranieri F, Musumeci G, Marra C, Manganotti P, Nardone R, Di Lazzaro V, Koch G, Borroni B.

Brain Stimul. 2021 Mar-Apr;14(2):241-249. doi: 10.1016/j.brs.2021.01.004. Epub 2021 Jan 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias